1. 850PIntermittent short course enzalutamide in biochemically recurrent prostate cancer: Analysis of PSA recovery, testosterone levels and tolerability. (23rd October 2018) Authors: Al Harthy, M; Singh, H; Karzai, F; Arlen, P; Theoret, M; Marte, J; Bilusic, M; Couvillon, A; Owens, H; Hankin, A; Cordes, L; Rosner, I; Strauss, J; Figg, W D; Schlom, J; Dahut, W; Gulley, J; Madan, R Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗